Autonomix CFO granted 15,000 restricted shares
Autonomix Medical’s CFO received a 15,000-share restricted stock award that vests in one year, increasing his direct holdings to 15,119 shares.
Rhea-AI Filing Summary
Autonomix Medical, Inc. (symbol: AMIX) is the issuer of record for a Form 4 filing submitted to the SEC. Smith Trent N. reported acquisition or exercise transactions in this Form 4 filing.
Autonomix Medical, Inc. (AMIX) reported that its chief financial officer, Trent N. Smith, received a grant of 15,000 shares of common stock on September 3, 2026 as a restricted stock award that vests one year from that date. Following this equity award, he directly holds 15,119 shares of Autonomix Medical common stock. No Rule 10b5-1 trading plan is reported for this transaction.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock F1 | 15,000 | -- | -- |
Footnotes (1)
- F1. Represents restricted stock award vesting one-year from the date of issuance of September 3, 2026.
Key Figures
Key Terms
restricted stock award financial
vesting financial
direct ownership financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did AMIX report for its CFO on September 3, 2026?
Was the AMIX CFO’s September 3, 2026 equity grant a purchase or a compensation award?
Was the AMIX CFO’s Form 4 transaction under a Rule 10b5-1 plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.